The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 53 , ISSUE 3 ( July-September, 2011 ) > List of Articles

EDITORIAL

Allergic Bronchopulmonary Aspergillosis: Lessons Learnt from Genetics

Ritesh Agarwal

Citation Information : Agarwal R. Allergic Bronchopulmonary Aspergillosis: Lessons Learnt from Genetics. Indian J Chest Dis Allied Sci 2011; 53 (3):137-140.

DOI: 10.5005/ijcdas-53-3-137

License: NA

Published Online: 10-09-2011

Copyright Statement:  NA


Abstract

PDF Share
  1. Agarwal R. Allergic bronchopulmonary aspergillosis. In: Jindal SK, Shankar PS, Raoof S, et al, editors Textbook of Pulmonary and Critical Care Medicine. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2010: pp 947-970.
  2. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009;135:805-26.
  3. Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis 2009;13: 936-44.
  4. Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis: a review and a report of eight new cases. Thorax 1952;7:317-33.
  5. Shah JR. Allergic bronchopulmonary aspergillosis. J Assoc Physicians India 1971;19:835-41.
  6. Agarwal R, Chakrabarti A. Clinical manifestations and natural history of allergic bronchopulmonary aspergillosis. In: Pasqualotto AC, editor. Aspergillosis: From Diagnosis to Prevention. New York: Springer; 2009: pp 707-24.
  7. Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 2006; 130:442-8.
  8. Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A, Jindal SK. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest 2007;132:1183-90.
  9. Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Saikia B, Chakrabarti A, et al. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir Med 2010;104:204-10.
  10. Agarwal R, Khan A, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on highattenuation mucus. PLoS One 2010;5:e15346.
  11. Patterson R, Greenberger PA, Halwig JM, Liotta JL, Roberts M. Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986;146:916-8.
  12. Agarwal R. Controversies in allergic bronchopulmonary aspergillosis. Int J Respir Care 2010;6:53-54, 56-63.
  13. Knutsen AP, Mueller KR, Levine AD, Chouhan B, Hutcheson PS, Slavin RG. Asp f I CD4+ TH2-like T-cell lines in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1994;94:215-21.
  14. Chauhan B, Knutsen A, Hutcheson PS, Slavin RG, Bellone CJ. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 1996;97:2324-31.
  15. Chauhan B, Santiago L, Kirschmann DA, Hauptfeld V, Knutsen AP, Hutcheson PS, et al. The association of HLADR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol 1997;159:4072-6.
  16. Schuyler M. The Th1/Th2 paradigm in allergic bronchopulmonary aspergillosis. J Lab Clin Med 1998;131:194-6.
  17. Knutsen AP, Bellone C, Kauffman H. Immunopathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis. J Cyst Fibros 2002;1:76-89.
  18. Bateman ED. A new look at the natural history of Aspergillus hypersensitivity in asthmatics. Respir Med 1994;88:325-7.
  19. Henderson AH. Allergic aspergillosis: review of 32 cases. Thorax 1968;23:513-23.
  20. Kramer MN, Kurup VP, Fink JN. Allergic bronchopulmonary aspergillosis from a contaminated dump site. Am Rev Respir Dis 1989;140:1086-8.
  21. Kagen SL, Kurup VP, Sohnle PG, Fink JN. Marijuana smoking and fungal sensitization. J Allergy Clin Immunol 1983;71:389-93.
  22. Allmers H, Huber H, Baur X. Two-year follow-up of a garbage collector with allergic bronchopulmonary aspergillosis (ABPA). Am J Ind Med 2000;37:438-42.
  23. Knutsen AP. Genetic and respiratory tract risk factors for aspergillosis: ABPA and asthma with fungal sensitization. Med Mycol 2006;44 (Suppl. 1):61-70.
  24. Flaherty DK, Surfus JE, Geller M, Rosenberg M, Patterson R, Reed CE. HLA antigen frequencies in allergic bronchopulmonary aspergillosis. Clin Allergy 1978;8:73-6.
  25. Morris MJ, Faux JA, Ting A, Morris PJ, Lane DJ. HLA-A, B and C and HLA-DR antigens in intrinsic and allergic asthma. Clin Allergy 1980;10:173-9.
  26. Miller PW, Hamosh A, Macek M, Jr, Greenberger PA, MacLean J, Walden SM, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996;59:45-51.
  27. Aron Y, Bienvenu T, Hubert D, Dusser D, Dall'Ava J, Polla BS. HLA-DR polymorphism in allergic broncho-pulmonary aspergillosis. J Allergy Clin Immunol 1999;104:891-2.
  28. Chauhan B, Santiago L, Hutcheson PS, Schwartz HJ, Spitznagel E, Castro M, et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000;106:723-9.
  29. Marchand E, Verellen-Dumoulin C, Mairesse M, Delaunois L, Brancaleone P, Rahier JF, et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001;119:762-7.
  30. Chauhan B, Hutcheson PS, Slavin RG, Bellone CJ. T-cell receptor bias in patients with allergic bronchopulmonary aspergillosis. Hum Immunol 2002;63:286-94.
  31. Eaton TE, Weiner Miller P, Garrett JE, Cutting GR. Cystic fibrosis transmembrane conductance regulator gene mutations: do they play a role in the aetiology of allergic bronchopulmonary aspergillosis? Clin Exp Allergy 2002;32:756-61.
  32. Saxena S, Madan T, Shah A, Muralidhar K, Sarma PU. Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2003;111:1001-7.
  33. Brouard J, Knauer N, Boelle PY, Corvol H, Henrion-Caude A, Flamant C, et al. Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis. J Infect Dis 2005;191:1988-91.
  34. Kurup VP, Raju R, Manickam P. Profile of gene expression in a murine model of allergic bronchopulmonary aspergillosis. Infect Immun 2005;73:4381-4.
  35. Madan T, Kaur S, Saxena S, Singh M, Kishore U, Thiel S, et al. Role of collectins in innate immunity against aspergillosis. Med Mycol 2005;43 (Suppl. 1):S155-S163.
  36. Kaur S, Gupta VK, Shah A, Thiel S, Sarma PU, Madan T. Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol 2006;143:414-9.
  37. Knutsen AP, Kariuki B, Consolino JD, Warrier MR. IL-4 alpha chain receptor (IL-4Ralpha) polymorphisms in allergic bronchopulmonary aspergillosis. Clin Mol Allergy 2006;4:3.
  38. Sambatakou H, Pravica V, Hutchinson IV, Denning DW. Cytokine profiling of pulmonary aspergillosis. Int J Immunogenet 2006;33:297-302.
  39. Vaid M, Kaur S, Sambatakou H, Madan T, Denning DW, Sarma PU. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med 2007;45:183-6.
  40. Carvalho A, Pasqualotto AC, Pitzurra L, Romani L, Denning DW, Rodrigues F. Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 2008;197:618-21.
  41. Lebecque P, Pepermans X, Marchand E, Leonard A, Leal T. ABPA in adulthood: a CFTR-related disorder. Thorax 2011; In Press.
  42. de Almeida MB, Bussamra MH, Rodrigues JC. Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients. Paediatr Respir Rev 2006;7:67-72.
  43. Tomee JF, Wierenga AT, Hiemstra PS, Kauffman HK. Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 1997;176:300-3.
  44. Tomee JF, Kauffman HF, Klimp AH, de Monchy JG, Koeter GH, Dubois AE. Immunologic significance of a collagen-derived culture filtrate containing proteolytic activity in Aspergillus-related diseases. J Allergy Clin Immunol 1994;93:768-78.
  45. Hogaboam CM, Blease K, Schuh JM. Cytokines and chemokines in allergic bronchopulmonary aspergillosis (ABPA) and experimental Aspergillus-induced allergic airway or asthmatic disease. Front Biosci 2003;8:e 147-56.
  46. Kauffman HF. Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling. Front Biosci 2003;8:e190-6.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.